Viridian Therapeutics, Inc.'s financial review
Viridian Therapeutics, Inc.'s Revenue (Yearly)
3.2M
Total Funding
29M
Last Funding Round
27M
Viridian Therapeutics, Inc. information
Viridian Therapeutics, Inc.'s financial review
Viridian Therapeutics, Inc.'s Revenue (Yearly)
3.2M
Total Funding
29M
Last Funding Round
27M
Technologies
Employees
Why our clients choose Apollo
“Apollo completely changed the game for us. It allowed us to identify relevant targets that are ready to scale and reach out to them at the exact right time.”
Head of Product, Kickfurther
“Using Apollo.io, we've solved the biggest problem for every business, the lead problem. We are now constrained by sales time and no longer lack interested prospects.”
CEO, Victorious